The cytotoxic Staphylococcus aureus PSMα3 reveals a cross-α amyloid-like fibril E Tayeb-Fligelman, O Tabachnikov, A Moshe, O Goldshmidt-Tran, ... Science 355 (6327), 831-833, 2017 | 296 | 2017 |
Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspired Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents S Perov, O Lidor, N Salinas, N Golan, E Tayeb-Fligelman, M Deshmukh, ... PLoS Pathog. 15 (8), e1007978, 2019 | 79 | 2019 |
Staphylococcus aureus PSMα3 cross-α fibril polymorphism and determinants of cytotoxicity E Tayeb-Fligelman, N Salinas, O Tabachnikov, M Landau Structure 28 (3), 301-313. e6, 2020 | 57 | 2020 |
Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C E Reinstein, A Gutierrez-Fernandez, S Tzur, C Bormans, S Marcu, ... European Journal of Human Genetics 24 (12), 1792-1796, 2016 | 47 | 2016 |
The amphibian antimicrobial peptide uperin 3.5 is a cross-α/cross-β chameleon functional amyloid N Salinas, E Tayeb-Fligelman, MD Sammito, D Bloch, R Jelinek, D Noy, ... Proceedings of the National Academy of Sciences 118 (3), e2014442118, 2021 | 43 | 2021 |
Reciprocal interactions between membrane bilayers and S. aureus PSMα3 cross-α amyloid fibrils account for species-specific cytotoxicity R Malishev, E Tayeb-Fligelman, S David, MM Meijler, M Landau, ... Journal of Molecular Biology 430 (10), 1431-1441, 2018 | 32 | 2018 |
The GPSM2/LGN GoLoco motifs are essential for hearing Y Bhonker, A Abu-Rayyan, K Ushakov, L Amir-Zilberstein, S Shivatzki, ... Mammalian Genome 27, 29-46, 2016 | 32 | 2016 |
Mutations in TAX1BP3 Cause Dilated Cardiomyopathy with Septo‐Optic Dysplasia E Reinstein, K Orvin, E Tayeb‐Fligelman, H Stiebel‐Kalish, S Tzur, ... Human Mutation 36 (4), 439-442, 2015 | 22 | 2015 |
Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2 E Tayeb-Fligelman, X Cheng, C Tai, JT Bowler, S Griner, MR Sawaya, ... BioRxiv, 2021.03. 05.434000, 2021 | 19 | 2021 |
Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils E Tayeb-Fligelman, JT Bowler, CE Tai, MR Sawaya, YX Jiang, G Garcia Jr, ... Nature communications 14 (1), 2379, 2023 | 7 | 2023 |
Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2. bioRxiv. 2021 E Tayeb-Fligelman, X Cheng, C Tai, JT Bowler, S Griner, MR Sawaya, ... preprint, 0 | 7 | |
X-ray structural study of amyloid-like fibrils of tau peptides bound to small-molecule ligands E Tayeb-Fligelman, M Landau Tau Protein: Methods and Protocols, 89-100, 2017 | 6 | 2017 |
The SARS-CoV-2 nucleocapsid protein preferentially binds long and structured RNAs CE Tai, E Tayeb-Fligelman, S Griner, L Salwinski, JT Bowler, ... bioRxiv, 2021.12. 25.474155, 2021 | 2 | 2021 |
Cryo-EM structures of the D290V mutant of the hnRNPA2 low-complexity domain suggests how D290V affects phase separation and aggregation J Lu, P Ge, MR Sawaya, MP Hughes, DR Boyer, Q Cao, R Abskharon, ... Journal of Biological Chemistry 300 (2), 2024 | 1 | 2024 |
Determinants of Staphylococcus aureus PSMα3 Cross-α Fibrils Toxicity E Tayeb-Fligelman, N Salinas, O Tabachnikov, M Landau bioRxiv, 452011, 2018 | 1 | 2018 |
Inhibition of amyloid formation of the Nucleoprotein of SARS-CoV-2 (preprint) E Tayeb-Fligelman, X Cheng, C Tai, JT Bowler, S Griner, MR Sawaya, ... | | 2021 |
Structural Insights into Curli Amyloid Fibrils suggest Repurposing Anti-amyloid Compounds as Anti-biofilm Agents S Perov, O Lidor, N Salinas, N Golan, E Tayeb-Fligelman, D Willbold, ... bioRxiv, 493668, 2018 | | 2018 |
New structure-activity paradigms for amyloids from pathogenic microbes E Tayeb-Fligelman, N Salinas, S Perov, O Tabachnikov, M Landau FEBS JOURNAL 284, 33-33, 2017 | | 2017 |
Design, Synthesis and Evaluation of Novel Aminoglycoside-based Scaffolds: Towads Treatment of Human Genetic Diseases E Tayeb-Fligelman Technion-Israel Institute of Technology, Faculty of Chemistry, 2012 | | 2012 |
The Amphibian An\microbial Pep\de Uperin 3.5 is a Cross-α/Cross-β Chameleon Func\onal Amyloid N Salinas, E Tayeb-Fligelman, M Sammito, D Bloch, R Jelinek, D Noy, ... | | |